ALLERGIC FUNGAL RHINOSINUSITIS

Clinical trials for ALLERGIC FUNGAL RHINOSINUSITIS explained in plain language.

Never miss a new study

Get alerted when new ALLERGIC FUNGAL RHINOSINUSITIS trials appear

Sign up with your email to follow new studies for ALLERGIC FUNGAL RHINOSINUSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug trial targets debilitating fungal sinus disease

Disease control Completed

This study tested whether the drug dupilumab could help control allergic fungal rhinosinusitis (AFRS), a severe sinus condition. It involved 62 adults and adolescents with confirmed AFRS who received either dupilumab or a placebo for a year. The main goal was to see if the drug c…

Matched conditions: ALLERGIC FUNGAL RHINOSINUSITIS

Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

ALLERGIC FUNGAL RHINOSINUSITIS

Get alerted when new ALLERGIC FUNGAL RHINOSINUSITIS trials appear

New drug trial targets debilitating fungal sinus disease